Compassionate use programmes enable people with life-threatening, long-lasting or seriously disabling illnesses to use drugs that have not yet been authorised. This is usually only for drugs that are near to drug approval, especially for people who would be excluded from research studies.
This is similar to, and sometimes called, a named-patient programme.
Information on compassionate access in the EU.